BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Nephrol. Sep 25, 2026; 15(3): 121887
Published online Sep 25, 2026. doi: 10.5527/wjn.121887
Figure 1
Figure 1 Immunopathology of complement-mediated membranoproliferative glomerulonephritis A: Mesangial and endocapillary hypercellularity with lobular accentuation (hematoxylin and eosin, × 400); B: Mesangial proliferation with almost diffuse inter-positioning into peripheral capillary loops (periodic acid-Schiff stain, × 400); C: Mesangiocapillary proliferation with double contour formation exhibiting tram track appearance (silver methenamine stain, × 400); D: Diffuse, bright, ring-like positivity of C3 with an intensity of 3+ on a scale of 0-3, predominantly in the mesangium on immunofluorescence. The rest of the immunoreactions were two orders of magnitude lower in intensity (≤ 1+; immunofluorescence, × 400).
Figure 2
Figure 2 Kaplan-Meier survival analysis curves. A comparison of survival rates between immune complex-mediated membranoproliferative glomerulonephritis and complement-mediated membranoproliferative glomerulonephritis patients analyzed using the log-rank test. IC-MPGN: Immune complex-mediated membranoproliferative glomerulonephritis; C-MPGN: Complement-mediated membranoproliferative glomerulonephritis.


Write to the Help Desk